Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2
Paul D. Wright(LifeArc), Alistair Mathie(University of Westminster), Yvonne Walsh(Medway School of Pharmacy), Emma L. Veale(Medway School of Pharmacy), David McCoull(LifeArc), L Byrom(LifeArc), Egle Gaurilcikaite(LifeArc), Jonathan M. Large(LifeArc), Jeff Jerman(LifeArc), Barbara W. Hadrys(LifeArc)
Cited by 21
Related Papers
Guide to Receptors and Channels (GRAC), 5th edition
|British Journal of Pharmacology|2011|1.9k
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
Guide to Receptors and Channels (GRAC), 3rd edition
|British Journal of Pharmacology|2008|508
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
|British Journal of Pharmacology|2019|505
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488